Atossa Therapeutics, Inc.ATOSNASDAQ
Loading
Operating Cash Flow Growth AcceleratingAccelerating
Percentile Rank93
Studio
Year-over-Year Change

Year-over-year operating cash flow growth rate

Latest
-0.43%
↑ 97% vs avg
Percentile
P93
Near historical high
Streak
3 yr
Consecutive growthAccelerating
Average
-12.76%
Historical baseline
PeriodValue
2024-0.43%
2023-0.87%
2022-26.03%
2021-42.36%
2020-26.75%
2019-1.86%
2018-35.91%
2017-22.69%
201661.48%
2015-32.19%